Photo: CHUTTERSNAP/ Unsplash.com
25 March, 2024
Copenhagen-based life sciences investor Novo Holdings is bolstering its focus on Asia by increasing its annual allocation for, and average ticket size in, the region.
Edited by: Pramod Mathew
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber?
Contact us for corporate subscriptions at
Printed by Unregistered user on Wed, 24 Apr 2024 14:43:51 GMT